Focal looks to reassure investors following criticism of sealant's US clinical trials
This article was originally published in Clinica
Executive Summary
Focal, a surgical sealant company, has been defending the results of its pivotal US clinical trials for its first product, FocalSeal-L, in recent meetings with investors.